L.B. Bohle demonstrating granulation and continuous manufacturing capabilities at MEDELPHARM Distribution Seminar

Ennigerloh, Germany: – World-respected builder of advanced systems for pharma production, L.B. Bohle, will demonstrate its advanced dry granulation and continuous production capabilities at the upcoming MEDELPHARM Distribution Seminar (MDS) in France.

L.B. Bohle will bring a team of experts to the Seminar to run demonstrations on its BRC Dry Granulator and its innovative QbCon^® 1 combined granulator and dryer for continuous manufacturing (CM).

Continuous Manufacturing Focus

The two-day MDELPHARM Distribution Seminar, commencing September 25 at the French compaction simulation specialist’s French headquarters at Beynost near Lyon, will feature a mix of presentations and application workshops tracing the powder transformation journey from research to commercial scale manufacturing.

It will offer invited attendees opportunities to go ‘hands on’ with a range of significant R&D and production equipment with the focus on the potential of CM to revolutionize the efficiencies of the pharma industry. The American FDA has estimated that some drugs that take a month to manufacture using conventional batch processing may take only one day under continuous manufacturing regimes.

Collaborators

L.B. Bohle will be a leading presence at the Workshop on several levels. Not only is MEDELPHARM the chosen French distributor for its products, but the two companies share a further link via MEDELPHARM’s parent company, global tableting leader KORSCH AG, with whom L.B. Bohle has a long-established strategic collaboration.

Alongside MEDELPHARM compaction simulators, KORSCH tableting press, and L.B. Bohle machinery, the seminar will also feature working installations from other industry names.

CM Pioneer

The L.B. Bohle team at the Seminar will highlight the company’s pioneering role in developing CM technologies and continuous production systems for solid dosage forms. It has shown how machines required for CM can be designed smaller, because they can produce the same or greater volume of product as conventional equipment within the same time frame.

L.B. Bohle has developed continuous production plants with the BRC Dry Granulator or QbCon^® 1, furthermore a semi-continuous film coater and automated continuous supervision and control of all critical process parameters.

The groundbreaking QbCon^® 1 is the world’s first truly continuous wet granulator and dryer for R&D applications and the only R&D system in the world that meets the quality requirements of pharmaceutical manufacturing. It features the short residence time of granules in the dryer, with narrow residence time distribution essential for removal of defective products without having to discard a large part of the batch. Additionally, narrow residence time distribution simplifies material traceability in the continuous process.

About L.B. Bohle

Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.

Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating, sorting, handling systems, cleaning and containment, process monitoring and continuous manufacturing.

The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency, but also strengthen competitive edge and sustainability.

To these ends, L.B. Bohle offers both complete production lines and solutions for individual production steps, focusing on rapid development and production of sophisticated, pragmatic, and customized applications.

The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally, it has sales and service subsidiaries in the USA (Warminster, PA) in India (headquarter in Ahmedabad and Innovation Center in Hyderabad), and in Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.

Further information at: www.lbbohle.com or  www.continuous-manufacturing.com  or  www.coating-tablets.com

About MEDELPHARM

Headquartered near Lyon, MEDELPHARM is a high-precision engineering company manufacturing R&D tablet presses and providing innovative solutions for powder analysis and formulation.

Since 1985, MEDELPHARM has been the specialist in tableting instruments ‘Made by people for people’, with high-speed and precision but at the same time very easy-to-use.

Since the end of 2022, it has been a member of the international KORSCH Group, enhancing its worldwide reach.

For more information, visit: www.medelpharm.com

Resources

Click on Continuous Granulation and Drying for the Pharmaceutical Industry  for further information on QbCon® 1.
Click on MEDELPHARM Distribution Seminar for event home page (French language).
Visit Bohle  Technology Center and Service Center virtually in a 360° tour.